T. Rowe Price Capital Appreciation Fund (PRWCX)

27.03
Net Asset Value
-0.22%
1 Day
+3.44%
Year-to-Date
Overall Morningstar Rating
Moderate allocation
Style or Category
No Load
Sales Expenses
0.71%
Expense Ratio
Average
Morningstar Risk Rating™
Investment Objective The investment seeks long-term capital appreciation. The fund will invest at least 50% of total assets in the common stocks of established U.S. companies that the managers believe have above-average potential for capital growth. The remaining assets are generally invested in convertible securities, corporate and government debt, bank loans (which represent an interest in amounts owed by a borrower to a syndicate of lenders), and foreign securities, in keeping with the fund's objective. It may invest up to 25% of its total assets in below investment-grade debt securities and bank loans and up to 10% of its total assets in mortgage- and asset-backed securities.

Performance

1 month+3.59% 3 years+14.91%
3 months+3.65% 5 years+13.44%
1 year+13.55% Since inception+11.50%
Data through --

Peer Comparisonvs. Moderate allocation

 PRWCXCategory
Performance 5-yr return+13.44%+9.43%
Expense ratio0.71%1.29%
Risk 5 year sharpe ratio1.401.07
Net assets$23.0B$2.9B
Average market cap$37.9B$46.4B
Average P/E21.917.4
Portfolio turnover72%72%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyT. Rowe Price
Fund manager & tenureDavid Giroux / 8 Years
Minimal initial investment$2,500.00
Minimum IRA investment$1,000.00

Holdings

U.S. stock55.88%
Fixed income26.71%
Cash9.89%
International stock6.55%
Other0.97%
Top 5 Sectors
Portfolio weighting
Financial service 19.82%
Industrial materials 16.26%
Healthcare 12.96%
Hardware 11.73%
Energy 10.00%
Top 10 Holdings
Portfolio weighting
DHR Danaher Corp4.53%
MMC Marsh & McLennan Companies Inc2.74%
TMO Thermo Fisher Scientific Inc2.69%
AZO Autozone Inc2.57%
FISV Fiserv Inc2.47%
STT State Street1.93%
PCG PG&E1.81%
LLY Eli Lilly and Co1.76%
AGN Allergan1.73%
PNR Pentair plc1.61%

To view my watchlist

Not a member yet?

Sign up now for a free account